{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:53:34Z","timestamp":1780926814920,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004530","name":"Universiti Putra Malaysia","doi-asserted-by":"publisher","award":["UPM\/800-3\/3\/1\/GPB\/2019\/9682500"],"award-info":[{"award-number":["UPM\/800-3\/3\/1\/GPB\/2019\/9682500"]}],"id":[{"id":"10.13039\/501100004530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemotherapy is widely used in cancer treatments. However, non-specific distribution of chemotherapeutic agents to healthy tissues and normal cells in the human body always leads to adverse side effects and disappointing therapeutic outcomes. Therefore, the main aim of this study was to develop a targeted drug delivery system based on the hepatitis B virus-like nanoparticle (VLNP) for specific delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells expressing epithelial growth factor receptor (EGFR). 5-FA was synthesized from 5-fluorouracil (5-FU), and it was found to be less toxic than the latter in cancer cells expressing different levels of EGFR. The cytotoxicity of 5-FA increased significantly after being conjugated on the VLNP. A cell penetrating peptide (CPP) of EGFR was displayed on the VLNP via the nanoglue concept, for targeted delivery of 5-FA to A431, HT29 and HeLa cells. The results showed that the VLNP displaying the CPP and harboring 5-FA internalized the cancer cells and killed them in an EGFR-dependent manner. This study demonstrated that the VLNP can be used to deliver chemically modified 5-FU derivatives to cancer cells overexpressing EGFR, expanding the applications of the VLNP in targeted delivery of chemotherapeutic agents to cancer cells overexpressing this transmembrane receptor.<\/jats:p>","DOI":"10.1038\/s41598-020-73967-4","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T10:03:22Z","timestamp":1602151402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles"],"prefix":"10.1038","volume":"10","author":[{"given":"Bee Koon","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Rullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chean Yeah","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Lian","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rahman","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorjahan Banu","family":"Alitheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Siang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"73967_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1254\/jjp.26.445","volume":"26","author":"T Ogiso","year":"1976","unstructured":"Ogiso, T., Noda, N., Asai, N. & Kato, Y. Antitumor agents. I. effect of 5-fluorouracil and cyclophosphamide on liver microsomes and thymus of rat. Jpn. J. Pharmacol.\u00a026, 445\u2013453 (1976).","journal-title":"Jpn. J. Pharmacol."},{"key":"73967_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1254\/jjp.28.175","volume":"28","author":"T Ogiso","year":"1978","unstructured":"Ogiso, T., Noda, N., Masuda, H. & Kato, Y. Antitumor agents. II. effect of 5-fluorouracil and cyclophosphamide on immunological parameters and liver microsomes of tumor-bearing rats. Jpn. J. Pharmacol.\u00a028, 175\u2013183 (1978).","journal-title":"Jpn. J. Pharmacol."},{"key":"73967_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0163-7258(90)90056-8","volume":"48","author":"WB Parker","year":"1990","unstructured":"Parker, W. B. & Cheng, Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 48, 381\u2013395 (1990).","journal-title":"Pharmacol. Ther."},{"key":"73967_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4172\/2161-0398.1000214","volume":"6","author":"S Chinnathambi","year":"2016","unstructured":"Chinnathambi, S., Karthikeyan, S., Kesherwani, M., Velmurugan, D. & Hanagata, N. Underlying the mechanism of 5-fluorouracil and human serum albumin interaction: a biophysical study. J. Phys. Chem. Biophys. 6, 214 (2016).","journal-title":"J. Phys. Chem. Biophys."},{"key":"73967_CR5","first-page":"82","volume":"19","author":"A Schalhorn","year":"1992","unstructured":"Schalhorn, A. & Kuhl, M. Clinical pharmacokinetics of fluorouracil and folinic acid. Semin. Oncol. 19, 82\u201392 (1992).","journal-title":"Semin. Oncol."},{"key":"73967_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3109\/07357909909032859","volume":"17","author":"L Iyer","year":"1999","unstructured":"Iyer, L. & Ratain, M. J. 5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapy. Cancer Invest. 17, 494\u2013506 (1999).","journal-title":"Cancer Invest."},{"key":"73967_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1081\/CBI-120002597","volume":"19","author":"G Milano","year":"2002","unstructured":"Milano, G. & Chamorey, A. L. Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics. Chronobiol. Int. 19, 177\u2013189 (2002).","journal-title":"Chronobiol. Int."},{"key":"73967_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0300-483X(95)03049-L","volume":"102","author":"DL Shuey","year":"1995","unstructured":"Shuey, D. L. et al. Biological modeling of 5-fluorouracil developmental toxicity. Toxicology 102, 207\u2013213 (1995).","journal-title":"Toxicology"},{"key":"73967_CR9","first-page":"33","volume":"13","author":"JS Macdonald","year":"1999","unstructured":"Macdonald, J. S. Toxicity of 5-fluorouracil. Oncology. 13, 33\u201334 (1999).","journal-title":"Oncology."},{"key":"73967_CR10","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1081\/NCN-200027624","volume":"23","author":"ABP van Kuilenburg","year":"2004","unstructured":"van Kuilenburg, A. B. P., Meinsma, R. & van Gennip, A. H. Pyrimidine degradation defects and severe 5-fluorouracil toxicity. Nucleos Nucleot. Nucl. 23, 1371\u20131375 (2004).","journal-title":"Nucleos Nucleot. Nucl."},{"key":"73967_CR11","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1021\/mp200389t","volume":"9","author":"KW Lee","year":"2012","unstructured":"Lee, K. W., Tey, B. T., Ho, K. L., Tejo, B. A. & Tan, W. S. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery. Mol. Pharm. 9, 2415\u20132423 (2012).","journal-title":"Mol. Pharm."},{"key":"73967_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5603\/FHC.a2014.0034","volume":"52","author":"J Ruczynski","year":"2014","unstructured":"Ruczynski, J. et al. Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells. Folia Histochem. Cytobiol. 52, 257\u2013269 (2014).","journal-title":"Folia Histochem. Cytobiol."},{"key":"73967_CR13","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1038\/s41598-018-26749-y","volume":"8","author":"BK Gan","year":"2018","unstructured":"Gan, B. K. et al. Targeted delivery of cell penetrating peptide virus-like nanoparticles to skin cancer cells. Sci. Rep. 8, 8499 (2018).","journal-title":"Sci. Rep."},{"key":"73967_CR14","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ijrobp.2003.11.041","volume":"59","author":"RS Herbst","year":"2004","unstructured":"Herbst, R. S. Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol. 59, S21\u2013S26 (2004).","journal-title":"Int. J. Radiat. Oncol."},{"key":"73967_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.drudis.2010.08.006","volume":"15","author":"R Misra","year":"2010","unstructured":"Misra, R., Acharya, S. & Sahoo, S. K. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov. Today 15, 842\u2013850 (2010).","journal-title":"Drug Discov. Today"},{"key":"73967_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ajps.2013.07.021","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Wang, W., Yang, J., Zhou, C. & Sun, J. pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J. Pharm. Sci. 8, 159\u2013167 (2013).","journal-title":"Asian J. Pharm. Sci."},{"key":"73967_CR17","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","volume":"65","author":"JL Markman","year":"2013","unstructured":"Markman, J. L., Rekechenetskiy, A., Holler, E. & Ljubimova, J. Y. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv. Drug Deliv. Rev. 65, 1866\u20131879 (2013).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"73967_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.18388\/abp.2016_1275","volume":"63","author":"M Zdanowicz","year":"2016","unstructured":"Zdanowicz, M. & Chroboczek, J. Virus-like particles as drug delivery vectors. Acta Biochim. Pol. 63, 469\u2013473 (2016).","journal-title":"Acta Biochim. Pol."},{"key":"73967_CR19","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/nano5041716","volume":"5","author":"R Mustafa","year":"2015","unstructured":"Mustafa, R., Luo, Y., Wu, Y., Guo, R. & Shi, X. Dendrimer-functionalized laponite nanodisks as a platform for anticancer drug delivery. Nanomater. 5, 1716\u20131731 (2015).","journal-title":"Nanomater."},{"key":"73967_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/btm2.10049","volume":"2","author":"MJ Rohovie","year":"2017","unstructured":"Rohovie, M. J., Nagasawa, M. & Swartz, J. R. Virus-like particles: next-generation nanoparticles for targeted therapeutic delivery. Bioeng. Transl. Med. 2, 43\u201357 (2017).","journal-title":"Bioeng. Transl. Med."},{"key":"73967_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/pharmaceutics9040046","volume":"9","author":"J Kydd","year":"2017","unstructured":"Kydd, J. et al. Targeting strategies for the combination treatment of cancer using drug delivery systems. Pharmaceutics 9, 46 (2017).","journal-title":"Pharmaceutics"},{"key":"73967_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1021\/bc1002532","volume":"22","author":"Q Zhao","year":"2011","unstructured":"Zhao, Q. et al. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug. Chem. 22, 346\u2013352 (2011).","journal-title":"Bioconjug. Chem."},{"key":"73967_CR23","doi-asserted-by":"publisher","first-page":"9242","DOI":"10.1021\/ja203286n","volume":"133","author":"JK Pokorski","year":"2011","unstructured":"Pokorski, J. K., Breitenkamp, K., Liepold, L. O., Qazi, S. & Finn, M. G. Functional virus-based polymer\u2013protein nanoparticles by atom transfer radical polymerization. J. Am. Chem. Soc. 133, 9242\u20139245 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"73967_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nchem.1442","volume":"4","author":"J Lucon","year":"2012","unstructured":"Lucon, J. et al. Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. Nat. Chem. 4, 781\u2013788 (2012).","journal-title":"Nat. Chem."},{"key":"73967_CR25","doi-asserted-by":"publisher","first-page":"25741","DOI":"10.1038\/srep25741","volume":"6","author":"S Tang","year":"2016","unstructured":"Tang, S., Xuan, B., Ye, X., Huang, Z. & Qian, Z. A modular vaccine development platform based on sortase-mediated site-specific tagging of antigens onto virus-like particles. Sci. Rep. 6, 25741 (2016).","journal-title":"Sci. Rep."},{"key":"73967_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/protein\/gzq069","volume":"24","author":"MG Mateu","year":"2010","unstructured":"Mateu, M. G. Virus engineering: functionalization and stabilization. Protein Eng. Des. Sel. 24, 53\u201363 (2010).","journal-title":"Protein Eng. Des. Sel."},{"key":"73967_CR27","doi-asserted-by":"crossref","unstructured":"Mateu, M. G. Assembly, engineering and applications of virus-based protein nanoparticles BT - protein-based engineered nanostructures. in (eds. Cortajarena, A. L. & Grove, T. Z.) 83\u2013120 (Springer International Publishing, 2016).","DOI":"10.1007\/978-3-319-39196-0_5"},{"key":"73967_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","volume":"34","author":"MO Mohsen","year":"2017","unstructured":"Mohsen, M. O., Zha, L., Cabral-Miranda, G. & Bachmann, M. F. Major findings and recent advances in virus-like particle (VLP)-based vaccines. Semin. Immunol. 34, 123\u2013132 (2017).","journal-title":"Semin. Immunol."},{"key":"73967_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jbiosc.2011.09.007","volume":"113","author":"WB Yap","year":"2012","unstructured":"Yap, W. B., Tey, B. T., Alitheen, N. B. M. & Tan, W. S. Display of the antigenic region of Nipah virus nucleocapsid protein on hepatitis B virus capsid. J. Biosci. Bioeng. 113, 26\u201329 (2012).","journal-title":"J. Biosci. Bioeng."},{"key":"73967_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/nano8040236","volume":"8","author":"R Biabanikhankahdani","year":"2018","unstructured":"Biabanikhankahdani, R., Ho, L. K., Alitheen, N. B. M. & Tan, S. W. A dual bioconjugated virus-like nanoparticle as a drug delivery system and comparison with a pH-responsive delivery system. Nanomaterials\u00a08, 236 (2018).","journal-title":"Nanomaterials"},{"key":"73967_CR31","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1093\/emboj\/17.23.6839","volume":"17","author":"B B\u00f6ttcher","year":"1998","unstructured":"B\u00f6ttcher, B. et al. Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection. EMBO J. 17, 6839\u20136845 (1998).","journal-title":"EMBO J."},{"key":"73967_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1515\/BC.2003.042","volume":"384","author":"WS Tan","year":"2003","unstructured":"Tan, W. S., Dyson, M. R. & Murray, K. Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen. Biol. Chem. 384, 363\u2013371 (2003).","journal-title":"Biol. Chem."},{"key":"73967_CR33","doi-asserted-by":"crossref","unstructured":"Tan, W. S., McNae, I. W., Ho, K. L. & Walkinshaw, M. D. Crystallization and X-ray analysis of the T = 4 particle of hepatitis B capsid protein with an N-terminal extension. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun.63, 642\u2013647 (2007).","DOI":"10.1107\/S1744309107033726"},{"key":"73967_CR34","doi-asserted-by":"publisher","first-page":"37891","DOI":"10.1038\/srep37891","volume":"6","author":"R Biabanikhankahdani","year":"2016","unstructured":"Biabanikhankahdani, R., Alitheen, N. B. M., Ho, K. L. & Tan, W. S. pH-responsive virus-like nanoparticles with enhanced tumour-targeting ligands for cancer drug delivery. Sci. Rep. 6, 37891 (2016).","journal-title":"Sci. Rep."},{"key":"73967_CR35","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1038\/s41598-017-05525-4","volume":"7","author":"R Biabanikhankahdani","year":"2017","unstructured":"Biabanikhankahdani, R., Bayat, S., Ho, K. L., Alitheen, N. B. M. & Tan, W. S. A simple add-and-display method for immobilisation of cancer drug on His-tagged virus-like nanoparticles for controlled drug delivery. Sci. Rep. 7, 5303 (2017).","journal-title":"Sci. Rep."},{"key":"73967_CR36","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/sj.gt.3302103","volume":"10","author":"VW Beusechem","year":"2003","unstructured":"Beusechem, V. W. et al. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Ther. 10, 1982\u20131991 (2003).","journal-title":"Gene Ther."},{"key":"73967_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0883911511431876","volume":"27","author":"ZJ Sun","year":"2012","unstructured":"Sun, Z. J. et al. A poly(glycerol-sebacate-(5-fluorouracil-1-acetic acid)) polymer with potential use for cancer therapy. J. Bioact. Compat. Polym. 27, 18\u201330 (2012).","journal-title":"J. Bioact. Compat. Polym."},{"key":"73967_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","volume":"48","author":"SD Steichen","year":"2013","unstructured":"Steichen, S. D., Caldorera-Moore, M. & Peppas, N. A. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur. J. Pharm. Sci. 48, 416\u2013427 (2013).","journal-title":"Eur. J. Pharm. Sci."},{"key":"73967_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejps.2017.04.005","volume":"104","author":"L Ramzy","year":"2017","unstructured":"Ramzy, L., Nasr, M., Metwally, A. A. & Awad, G. A. S. Cancer nanotheranostics: a review of the role of conjugated ligands for overexpressed receptors. Eur. J. Pharm. Sci. 104, 273\u2013292 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"73967_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1040-8428(00)00134-7","volume":"38","author":"XD Yang","year":"2001","unstructured":"Yang, X. D., Jia, X. C., Corvalan, J. R., Wang, P. & Davis, C. G. Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy. Crit. Rev. Oncol. Hematol. 38, 17\u201323 (2001).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"73967_CR41","first-page":"2316","volume":"9","author":"ML Janmaat","year":"2003","unstructured":"Janmaat, M. L., Kruyt, F. A. E., Rodriguez, J. A. & Giaccone, G. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways. Clin. Cancer Res. 9, 2316\u20132326 (2003).","journal-title":"Clin. Cancer Res."},{"key":"73967_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","volume":"436","author":"MJ Akhtar","year":"2014","unstructured":"Akhtar, M. J., Ahamed, M., Alhadlaq, H. A., Alrokayan, S. A. & Kumar, S. Targeted anticancer therapy: overexpressed receptors and nanotechnology. Clin. Chim. Acta. 436, 78\u201392 (2014).","journal-title":"Clin. Chim. Acta."},{"key":"73967_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0169-409X(99)00041-1","volume":"40","author":"A Nagayasu","year":"1999","unstructured":"Nagayasu, A., Uchiyama, K. & Kiwada, H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. 40, 75\u201387 (1999).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"73967_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1248\/bpb.28.387","volume":"28","author":"YZ Huang","year":"2005","unstructured":"Huang, Y. Z., Gao, J. Q., Liang, W. Q. & Nakagawa, S. Preparation and characterization of liposomes encapsulating chitosan nanoparticles. Biol. Pharm. Bull. 28, 387\u2013390 (2005).","journal-title":"Biol. Pharm. Bull."},{"key":"73967_CR45","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia, H. K. & Siegel, S. J. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3, 1377\u20131397 (2011).","journal-title":"Polymers"},{"key":"73967_CR46","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1002\/jps.23691","volume":"102","author":"AS Narang","year":"2013","unstructured":"Narang, A. S., Chang, R.-K. & Hussain, M. A. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems. J. Pharm. Sci. 102, 3867\u20133882 (2013).","journal-title":"J. Pharm. Sci."},{"key":"73967_CR47","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1016\/j.ejmech.2011.04.010","volume":"46","author":"P Daumar","year":"2011","unstructured":"Daumar, P. et al. Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs. Eur. J. Med. Chem. 46, 2867\u20132879 (2011).","journal-title":"Eur. J. Med. Chem."},{"key":"73967_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00044-009-9291-8","volume":"20","author":"HP Li","year":"2011","unstructured":"Li, H. P., Wang, Z. D. & Yu, T. Microwave irradiation synthesis of novel ramose chitosan-based-5- fluorouracil and research on its in vitro release. Med. Chem. Res. 20, 67\u201373 (2011).","journal-title":"Med. Chem. Res."},{"key":"73967_CR49","doi-asserted-by":"publisher","first-page":"11748","DOI":"10.1021\/ja505212y","volume":"136","author":"P Huang","year":"2014","unstructured":"Huang, P. et al. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J. Am. Chem. Soc. 136, 11748\u201311756 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"73967_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00044-007-9049-0","volume":"16","author":"QW Wang","year":"2007","unstructured":"Wang, Q. W. et al. Synthesis and evaluation of the 5-fluorouracil-pectin conjugate targeted at the colon. Med. Chem. Res. 16, 370\u2013379 (2007).","journal-title":"Med. Chem. Res."},{"key":"73967_CR51","doi-asserted-by":"crossref","unstructured":"Sauraj, Kumar, S. U., Gopinath, P. & Negi, Y. S. Synthesis and bio-evaluation of xylan-5-fluorouracil-1-acetic acid conjugates as prodrugs for colon cancer treatment. Carbohydr. Polym.157, 1442\u20131450 (2017).","DOI":"10.1016\/j.carbpol.2016.09.096"},{"key":"73967_CR52","first-page":"142","volume":"18","author":"ZY Yang","year":"2000","unstructured":"Yang, Z. Y., Wang, L. F., Yang, X. P., Wang, D. & Li, Y. M. Pharmacological study on antitumor activity of 5-fluorouracil-1-acetic acid and its rare earth complexes. J. Rare Earths 18, 142\u2013143 (2000).","journal-title":"J. Rare Earths"},{"key":"73967_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1773-2247(09)50005-6","volume":"19","author":"M Imoto","year":"2009","unstructured":"Imoto, M., Azuma, H., Yamamoto, I., Otagiri, M. & Imai, T. Permeability of 5-fluorouracil and its prodrugs in Caco-2 cell monolayers: evidence for shift from paracellular to transcellular transport by prodrug formation. J. Drug Deliv. Sci. Technol. 19, 37\u201341 (2009).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"73967_CR54","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1246\/bcsj.48.3427","volume":"48","author":"M Tada","year":"1975","unstructured":"Tada, M. Antineoplastic agents: the preparation of 5-fluorouracil-1-acetic acid derivatives. Bull. Chem. Soc. Jpn. 48, 3427\u20133428 (1975).","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"73967_CR55","unstructured":"Cooper, G. M. The cell\u202f: a molecular approach. (ASM Press\u202f; Sinauer Associates, 2000)."},{"key":"73967_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jcp.1041040305","volume":"104","author":"RM Wohlhueter","year":"1980","unstructured":"Wohlhueter, R. M., McIvor, R. S. & Plagemann, P. G. W. Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells. J. Cell. Physiol. 104, 309\u2013319 (1980).","journal-title":"J. Cell. Physiol."},{"key":"73967_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0378-5173(91)90127-A","volume":"68","author":"SM Chung","year":"1991","unstructured":"Chung, S. M. et al. Pharmacokinetics of 5-fluorouracil after intravenous infusion of 5-fluorouracil-acetic acid-human serum albumin conjugates to rabbits. Int. J. Pharm.\u00a068, 61\u201368 (1991).","journal-title":"Int. J. Pharm."},{"key":"73967_CR58","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.carbpol.2011.11.039","volume":"87","author":"Q Luo","year":"2012","unstructured":"Luo, Q., Wang, P., Miao, Y., He, H. & Tang, X. A novel 5-fluorouracil prodrug using hydroxyethyl starch as a macromolecular carrier for sustained release. Carbohydr. Polym. 87, 2642\u20132647 (2012).","journal-title":"Carbohydr. Polym."},{"key":"73967_CR59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.biomaterials.2016.12.012","volume":"120","author":"IF Mohamed Suffian","year":"2017","unstructured":"Mohamed Suffian, I. F. et al. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo. Biomaterials\u00a0120, 126\u2013138 (2017).","journal-title":"Biomaterials"},{"key":"73967_CR60","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1590\/S0103-50532011000200017","volume":"22","author":"L Yang","year":"2011","unstructured":"Yang, L., Zhao, C. Y. & Liu, Y. Q. Synthesis and biological evaluation of novel conjugates of camptothecin and 5-flurouracil as cytotoxic agents. J. Brazil. Chem. Soc. 22, 308\u2013318 (2011).","journal-title":"J. Brazil. Chem. Soc."},{"key":"73967_CR61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/10717544.2012.714809","volume":"19","author":"B Jiang","year":"2012","unstructured":"Jiang, B. et al. Dual-targeting delivery system for bone cancer: synthesis and preliminary biological evaluation. Drug Deliv. 19, 317\u2013326 (2012).","journal-title":"Drug Deliv."},{"key":"73967_CR62","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1368-8375(99)00079-2","volume":"36","author":"D Tong","year":"2000","unstructured":"Tong, D., Poot, M., Hu, D. & Oda, D. 5-fluorouracil-induced apoptosis in cultured oral cancer cells. Oral Oncol. 36, 236\u2013241 (2000).","journal-title":"Oral Oncol."},{"key":"73967_CR63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1756-9966-31-60","volume":"31","author":"M Lamberti","year":"2012","unstructured":"Lamberti, M. et al. 5-fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. J. Exp. Clin. Cancer Res. 31, 60 (2012).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"73967_CR64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3892\/ol.2014.2211","volume":"8","author":"NM Mhaidat","year":"2014","unstructured":"Mhaidat, N. M., Bouklihacene, M. & Thorne, R. F. 5-fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-\u03b4. Oncol. Lett. 8, 699\u2013704 (2014).","journal-title":"Oncol. Lett."},{"key":"73967_CR65","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/10717544.2016.1264499","volume":"24","author":"C Huang","year":"2017","unstructured":"Huang, C. et al. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy. Drug Deliv. 24, 459\u2013466 (2017).","journal-title":"Drug Deliv."},{"key":"73967_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ymeth.2013.03.020","volume":"61","author":"ME Christensen","year":"2013","unstructured":"Christensen, M. E., Jansen, E. S., Sanchez, W. & Waterhouse, N. J. Flow cytometry based assays for the measurement of apoptosis-associated mitochondrial membrane depolarisation and cytochrome c release. Methods 61, 138\u2013145 (2013).","journal-title":"Methods"},{"key":"73967_CR67","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/elps.201200257","volume":"34","author":"KY Yoon","year":"2013","unstructured":"Yoon, K. Y., Tan, W. S., Tey, B. T., Lee, K. W. & Ho, K. L. Native agarose gel electrophoresis and electroelution: a fast and cost-effective method to separate the small and large hepatitis B capsids. Electrophoresis 34, 244\u2013253 (2013).","journal-title":"Electrophoresis"},{"key":"73967_CR68","unstructured":"DeLano, W. L. The PyMOL molecular graphics system. https:\/\/www.pymol.org (2002)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73967-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73967-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73967-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:54:01Z","timestamp":1670360041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73967-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73967"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73967-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16867"}}